Does AMLODIPINE Cause Ventricular hypertrophy? 46 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Ventricular hypertrophy have been filed in association with AMLODIPINE (Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide). This represents 0.1% of all adverse event reports for AMLODIPINE.
46
Reports of Ventricular hypertrophy with AMLODIPINE
0.1%
of all AMLODIPINE reports
12
Deaths
37
Hospitalizations
How Dangerous Is Ventricular hypertrophy From AMLODIPINE?
Of the 46 reports, 12 (26.1%) resulted in death, 37 (80.4%) required hospitalization, and 13 (28.3%) were considered life-threatening.
Is Ventricular hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMLODIPINE. However, 46 reports have been filed with the FAERS database.
What Other Side Effects Does AMLODIPINE Cause?
Hypotension (6,504)
Toxicity to various agents (5,554)
Completed suicide (5,267)
Drug ineffective (4,091)
Dyspnoea (3,907)
Dizziness (3,536)
Intentional overdose (3,427)
Fall (3,215)
Fatigue (3,141)
Headache (2,907)
What Other Drugs Cause Ventricular hypertrophy?
PREDNISONE (37)
PANTOPRAZOLE (36)
ASPIRIN (32)
VALSARTAN (29)
CLOZAPINE (28)
ACETAMINOPHEN (27)
TIOTROPIUM (24)
ALBUTEROL (21)
ONDANSETRON (21)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (20)
Which AMLODIPINE Alternatives Have Lower Ventricular hypertrophy Risk?
AMLODIPINE vs AMLODIPINE BESILATE
AMLODIPINE vs AMLODIPINE\ATORVASTATIN
AMLODIPINE vs AMLODIPINE\BENAZEPRIL
AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN
AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL